Essais liés4clinical trials
VilleWest Des Moineslocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04396574

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
Lasmiditan Migraine Phase 3 NCT04396236 PIONEER-PEDS1 — A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine TERMINATED
Lasmiditan Migraine Phase 3 NCT04396574 PIONEER-PEDS2 — A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine TERMINATED
Rimegepant (PF-07899801) Migraine Phase 3 NCT04743141 Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine RECRUITING
TNX-1900 Migraine Phase 2 NCT05679908 PREVENTION — A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine COMPLETED